Literature DB >> 11438131

Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births.

G C Smith1, J P Pell, D Walsh.   

Abstract

BACKGROUND: Individuals who are small at birth are at increased risk of ischaemic heart disease (IHD) in later life. One hypothesis to explain this association is fetal adaptation to a suboptimum intrauterine environment. We investigated whether pregnancy complications associated with low birthweight are related to risk of subsequent IHD in the mother.
METHODS: Routine discharge data were used to identify all singleton first births in Scotland between 1981 and 1985. Linkage to the mothers' subsequent admissions and deaths provided 15--19 years of follow-up. The mothers' risks of death from any cause or from IHD and admission for or death from IHD were related to adverse obstetric outcomes in the first pregnancy. Hazard ratios were adjusted for socioeconomic deprivation, maternal height and age, and essential hypertension.
FINDINGS: Complete data were available on 129,920 (95.6%) eligible deliveries. Maternal risk of IHD admission or death was associated with delivering a baby in the lowest birthweight quintile for gestational age (adjusted hazard ratio 1.9 [95% CI 1.5--2.4]), preterm delivery (1.8 [1.3--2.5]), and pre-eclampsia (2.0 [1.5--2.5]). The associations were additive; women with all three characteristics had a risk of IHD admission or death seven times (95% CI 3.3--14.5) greater than the reference category.
INTERPRETATION: Complications of pregnancy linked to low birthweight are associated with an increased risk of subsequent IHD in the mother. Common genetic risk factors might explain the link between birthweight and risk of IHD in both the individual and the mother.

Entities:  

Mesh:

Year:  2001        PMID: 11438131     DOI: 10.1016/S0140-6736(00)05112-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  221 in total

1.  Spontaneous loss of early pregnancy and risk of ischaemic heart disease in later life: retrospective cohort study.

Authors:  Gordon C S Smith; Jill P Pell; David Walsh
Journal:  BMJ       Date:  2003-02-22

Review 2.  Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease.

Authors:  M Ángeles Martínez-Zamora; Ricard Cervera; Juan Balasch
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

Review 3.  Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?

Authors:  Naveed Sattar; Ian A Greer
Journal:  BMJ       Date:  2002-07-20

Review 4.  Management of hypertension before, during, and after pregnancy.

Authors:  P Rachael James; Catherine Nelson-Piercy
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

5.  Prepregnancy lipids related to preterm birth risk: the coronary artery risk development in young adults study.

Authors:  Janet M Catov; Roberta B Ness; Melissa F Wellons; David R Jacobs; James M Roberts; Erica P Gunderson
Journal:  J Clin Endocrinol Metab       Date:  2010-05-25       Impact factor: 5.958

Review 6.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

7.  Predicting the Risk to Develop Preeclampsia in the First Trimester Combining Promoter Variant -98A/C of LGALS13 (Placental Protein 13), Black Ethnicity, Previous Preeclampsia, Obesity, and Maternal Age.

Authors:  Liora Madar-Shapiro; Ido Karady; Alla Trahtenherts; Argryo Syngelaki; Ranjit Akolekar; Liona Poon; Ruth Cohen; Adi Sharabi-Nov; Berthold Huppertz; Marei Sammar; Kata Juhasz; Nandor Gabor Than; Zoltan Papp; Roberto Romero; Kypros H Nicolaides; Hamutal Meiri
Journal:  Fetal Diagn Ther       Date:  2017-07-21       Impact factor: 2.587

8.  Impaired autophagy by soluble endoglin, under physiological hypoxia in early pregnant period, is involved in poor placentation in preeclampsia.

Authors:  Akitoshi Nakashima; Mikiko Yamanaka-Tatematsu; Naonobu Fujita; Keiichi Koizumi; Tomoko Shima; Toshiko Yoshida; Toshio Nikaido; Aikou Okamoto; Tamotsu Yoshimori; Shigeru Saito
Journal:  Autophagy       Date:  2013-01-15       Impact factor: 16.016

9.  Increased plasma norepinephrine levels in previously pre-eclamptic women.

Authors:  K H Lampinen; M Rönnback; P-H Groop; M G Nicholls; T G Yandle; R J Kaaja
Journal:  J Hum Hypertens       Date:  2013-09-19       Impact factor: 3.012

Review 10.  Drug treatment of hypertension in pregnancy.

Authors:  Catherine M Brown; Vesna D Garovic
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.